Skip to content
HealthyStudy
Menu

A reference, not a pharmacy

What the FDA label actually says, without the sales pitch

HealthyStudy takes the prescribing information that manufacturers filed with the US Food and Drug Administration and lays it out so it can be read.

Approved uses, strengths, warnings and contraindications, each linked back to the document it came from. We do not sell anything, we do not link to sellers of prescription medication, and we do not tell anyone what to take.

Semaglutide: highlights of the labels

Wegovy
Weight management, and cardiovascular risk in heart diseasecovers weight loss
Ozempic injection
Type 2 diabetes, with cardiovascular and kidney indicationsnot weight loss
Rybelsus and Ozempic tablets
Type 2 diabetesnot weight loss
Boxed warning
WARNING: RISK OF THYROID C-CELL TUMORS
Every medication page opens with this panel: one row per brand, and what that brand's own label approves it for.

The catalogue in numbers

medications
26
FDA labels read
40
side by side comparisons
24
links to sellers
0

Start with a comparison

Labels exist for every medication. What does not exist is a straight answer to how two of them differ. These pages put the two labels side by side and stop short of saying which is better, because the labels do not say that either.

Kept here, nowhere else

When the FDA rewrites a label, it does it quietly

There is no notice, no changelog and no feed. We compare each new revision with the one it replaced and write down what changed.

The full record of label changes
  1. Ozempic injectionapproved uses, warnings and precautions, forms and strengths changed30 July 2026
  2. 19 labels watched for revisions, checked against DailyMed every third day.RSS

Where this comes from

Facts belong to the regulator. Explanations and comparisons are written by us and marked as ours on the page, next to the paragraph they belong to. Nothing here is written by an anonymous medical reviewer who does not exist.

How we source and what we refuse to publish
  1. 01FetchThe label the manufacturer filed, through openFDA and DailyMed, both published by the US National Library of Medicine.
  2. 02ExtractApproved uses, strengths, dosing, warnings, contraindications and interactions, taken section by section rather than retyped.
  3. 03PublishWith the label version, its effective date and a link to the source document on every page it was used on.

The catalogue, drawn from itself

One plate per label. Each stripe is a section of the document, each division in a stripe one entry in that section, each red bar a boxed warning.

An abstract plate for each of the 40 FDA labels in the catalogue, drawn from their contents.